Home »
1999 Issues »
64 FR (09/22/1999) » 99-24609. Notice Pursuant to the National Cooperative Research and Production Act of 1993Inter Company Collaboration for AIDS Drug Development
99-24609. Notice Pursuant to the National Cooperative Research and Production Act of 1993Inter Company Collaboration for AIDS Drug Development
[Federal Register Volume 64, Number 183 (Wednesday, September 22, 1999)]
[Notices]
[Page 51337]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-24609]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Inter Company Collaboration for AIDS Drug
Development
Notice is hereby given that, on June 29, 1999, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. Sec. 4310 et seq. (``the Act''), Inter Company Collaboration
for AIDS Drug Development (the ``Collaboration'') has filed written
notification simultaneously with the Attorney General and the Federal
Trade Commission disclosing changes in its membership status. The
notifications were filed for the purpose of extending the Act's
provisions limiting the recovery of antitrust plaintiffs to actual
damages under specified circumstances. Specifically, although no
changes have been made in the membership of the Collaboration,
Collaboration member Astra AB of Sweden merged with Zeneca Group PLC of
the United Kingdom to form AstraZeneca PLC, a United Kingdom public
limited company. In addition, Collaboration member Agouron
Pharmaceuticals, Inc. of La Jolla, California has become a wholly owned
subsidiary of Warner-Lambert Company of Morris Plains, New Jersey.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and Inter Company Collaboration for AIDS
Drug Development intends to file additional written notification
disclosing all changes in membership.
On May 27, 1993, Inter Company Collaboration for AIDS Drug
Development filed its original notification to Section 6(a) of the Act.
The Department of Justice published a notice in the Federal Register
pursuant to Section 6(b) of the Act on July 6, 1993 (58 FR 36223).
The last notification was filed with the Department on November 30,
1998. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on January 29, 1999 (64 FR 4707).
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 99-24609 Filed 9-21-99; 8:45 am]
BILLING CODE 4410-11-M
Document Information
- Published:
- 09/22/1999
- Department:
- Antitrust Division
- Entry Type:
- Notice
- Document Number:
- 99-24609
- Pages:
- 51337-51337 (1 pages)
- PDF File:
-
99-24609.pdf